Rubius Therapeutics Inc
Biotechnology
Healthcare
RUBY
89.92 M shares
NASDAQ US
traded
10 May 2022
listed
yes
open
1.70
52 week high
28.43
high
1.70
52 week low
1.33
previous Close
1.33
P/E ratio
market cap
117 M
div yield
0
net incoming
-52.41 M
73.33 %
net profit margin
-5241200000.00 %
0.00 %
operating incoming
-50.86 M
73.87 %
net change in cash
-127.91 M
-235.10 %
cash on hand
98.10 M
-56.56 %
top